vimarsana.com

Latest Breaking News On - Neurocritical care society - Page 3 : vimarsana.com

Acasti Announces First Quarter 2024 Financial Results and Business Highlights

Managing New-Onset Refractory Status Epilepticus

A rare condition that presents with refractory and many times super-refractory status epilepticus, NORSE, including its subtype febrile infection related epilepsy syndrome (FIRES), is heterogeneous without one single etiology.

Marinus Pharmaceuticals, Inc (NASDAQ:MRNS) Q1 2023 Earnings Call Transcript

Operator: Greetings and welcome to the Marinus Pharmaceuticals’ First Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.